Autopsy report · NCT07653750

Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis

“We were able to test our hypothesis using the current data”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years before it started.
• Ran for about 4 years 11 months before it stopped.
• 62 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University Hospital, Clermont-Ferrand

Sponsor type

University, hospital or other

Conditions

Moderate to Severe Ulcerative Colitis

Interventions

Serum and fecal measurements

Participants

62

Sites

1

Countries

France

Trials that died the same way

• Radiofrequency Ablation of Ectopic Atrial Tachycardia
  “significant conclusive data has been collected” (57% match in meaning)
• A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)
  “Upon interim analysis, sufficient data was accrued to assess study hypotheses.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.